GSK2236805
GSK2236805 is a potent hepatitis C virus inhibitor with pEC50 values of 10.4, 11.1 for HCV genotype 1a (gt1a) and gt1b, respectively[1].
Product Specifications
CAS Number
1256390-53-0
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gsk2236805.html
Solubility
10 mM in DMSO
Smiles
O=C(OC)N[C@H](C(N1[C@H](C2=NC(C3=CC=C(C4=CC=C(C5=CNC([C@H](C6)N(C([C@@H](NC(OC)=O)C(C)C)=O)CC76OCCO7)=N5)C=C4)C=C3)=CN2)CCC1)=O)C(C)C
Molecular Formula
C42H52N8O8
Molecular Weight
796.91
References & Citations
[1]Kazmierski WM, et al. Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound. J Med Chem. 2014 Mar 13;57 (5) :2058-73.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472839-100 1x 100 µL
Desmoglein-3 (Squamous Cell Marker) (DSG3/2839), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 